Previous 10 | Next 10 |
United Therapeutics (Nasdaq: UTHR ), a public benefit corporation, today announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2024 . This award is presented by Newsweek and Statista Inc., the world-leading statistics po...
2023-12-03 12:00:30 ET More on SPDR S&P Biotech ETF Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Biopharma Bounce-Back: From Policy Pains To Profitable Plains Biotechs rally with gene editing stocks among nota...
2023-12-01 10:17:15 ET The UBS pharma equity team is out with a quant list of most crowded stocks on the long and short side. Crowding is a sentiment metric that basically measure popularity in positioning (long or short). It indicates if a stock has a significantly above-average number...
2023-11-25 03:20:10 ET Summary Latest revenue results are not favorable for MannKind nor United. MannKind needs to decide if Afrezza will be a reliable source of revenue or a drag on future revenues. United has been an unreliable partner for future use of MannKind's technology...
2023-11-09 11:12:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re a fan of the hit TV show Shark Tank , you’ve probably come across the intriguing term “unicorn” companies. Indeed, these fantastical entities are not o...
2023-11-08 14:42:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In October, I warned investors that flying car firm EHang (NASDAQ: EH ) had an order book that looked suspiciously weak : During the most recent quarter, EHang delivered j...
2023-11-07 11:20:54 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips EHang (NASDAQ: EH ) stock is taking a plunge after Hindenburg Research published a short report on the Chinese electric vertical take-off and landing (eVTOL) company. In...
2023-11-01 14:38:07 ET United Therapeutics Corporation (UTHR) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Company Participants Dewey Steadman – Head of Investor Relations Martine Rothblatt – Chairperson and Chief Executive Officer M...
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
2023-11-01 06:04:01 ET More on United Therapeutics United Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat United Therapeutics: Both Fundamental And Technical Analyses Justify A Buy Decision United Therapeutics: Eyeing A Re-Rating To 12-13x P/E, Growth M...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
United Therapeutics Corporation (Nasdaq: UTHR ), announced today that it will report its second quarter 2024 financial results before the market opens on Wednesday, July 31, 2024. A press release detailing the quarterly results will be issued that day at approximately 6:30 a.m. Eastern Time. ...
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...